Treatment of NREM Parasomnia
The treatment of NREM parasomnia should begin with safety measures and behavioral interventions, followed by pharmacotherapy with clonazepam (0.5-1mg at bedtime) for persistent cases with risk of injury. 1
Understanding NREM Parasomnias
- NREM parasomnias are undesirable non-deliberate physical or emotional events that occur during sleep, most commonly during entry into sleep or during arousals 1
- Common manifestations include sleepwalking, night terrors, confusional arousals, and sleep-related eating disorder 1
- NREM parasomnias are more common in children, while REM sleep behavior disorder (RBD) is more prevalent in older adults 1
Treatment Approach
First-Line: Safety Measures and Behavioral Interventions
Environmental safety modifications:
Behavioral and psychological interventions:
Second-Line: Pharmacotherapy
When behavioral interventions are insufficient and episodes pose risk of injury:
Benzodiazepines:
- Clonazepam (0.5-1mg at bedtime) is the most commonly prescribed medication 1, 2
- Effective in approximately 90% of cases 1
- May be taken 1-2 hours before bedtime if sleep onset insomnia or morning drowsiness occurs 1
- Caution in older adults as it appears on the American Geriatrics Society Beers Criteria list of potentially inappropriate medications 1
Alternative medications:
Special Considerations
- Medication review: Evaluate and discontinue medications that may exacerbate parasomnias, particularly sedative-hypnotics 5
- Underlying conditions: Identify and treat comorbid sleep disorders or neurological conditions that may trigger episodes 2, 5
- Monitoring: Regular follow-up to assess treatment efficacy and adjust interventions as needed 3
Treatment Efficacy
- In a large retrospective study of 512 patients with NREM parasomnia, 97.2% reported adequate symptom control with treatment 2
- Approximately 60% required pharmacotherapy, while 32% achieved control with non-pharmacological interventions alone 2
- Benzodiazepines were the most commonly prescribed effective medications (47.1%) 2
Pitfalls to Avoid
- Failing to address underlying sleep disorders that may trigger parasomnias 2
- Overlooking safety measures, which should be implemented regardless of pharmacotherapy 1
- Not considering the potential for medication-induced parasomnias, particularly with sedative-hypnotics 5
- Treating without proper diagnosis - polysomnography may be needed to differentiate from other sleep disorders 1